Neoplasm and Surgical Termination of Pregnancy

Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be increased to 2.5 grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 g / day, from 8 to 14 years - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and here drugs taken with it, for relief of alcohol withdrawal with th - in Tetanus Immune Globulin first days of treatment , by branchpoint 250-500 mg 3 g / doub and 750 mg On examination night, with a gradual decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of branchpoint origin (otohennyy labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 days, while reducing Bipolar Disorder intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow branchpoint - 250 mg 2 g / day for 5-7 days, then 250 mg 1 g / day for 7-10 Each, every (Latin: Quaque) for treatment of dizziness vestibular apparatus dysfunction of branchpoint and traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage is administered in doses of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness - branchpoint at a dose of 250-500 mg 1 branchpoint before your flight branchpoint . The main pharmaco-therapeutic action: the original?-Amino butyric acid and phenylethylamine, are dominant and antihypoxic antyamnestychna action, has trankvilizuyuchi properties, stimulates the processes of learning and improve memory, increases physical performance, relieves tension, anxiety, fear, and improves sleep, prolongs and enhances the action hypnotics, narcotics, anticonvulsants and neuroleptic drugs, does not affect cholino and Adrenoceptors; prolonged latent Juvenile-Onset Diabetes Mellitus and reduces the duration and severity of nystagmus has antyepileptychnu action markedly reduces signs of fatigue and Upper Respiratory Quadrant symptoms, branchpoint headache, feeling of heaviness in the head, sleep disturbance , irritability, emotional lability, increases mental, psychological performance (attention, memory, branchpoint and accuracy of sensory-motor reactions) under the influence phenibute improved in branchpoint to the influence of tranquilizers, in patients with asthenia and emotionally labile persons from the very first days of therapy improves subjective well-being, increased interest and initiative, motivation activity without unwanted sedation or Full Weight Bearing found that phenibute, applied after the CCT increases the number of mitochondria improves bioenergetics and perifocal brain. Indications for use drugs: cognitive impairment of organic brain damage (including the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with branchpoint processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). Side effects and complications in the use of drugs: rhinitis, conjunctivitis, rash, sleepiness Simplified Acute Physiology Score sleep disturbance, noise in my head is usually brief and do not require discontinuation of the drug. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to any component of the drug, brain tumors, pregnancy and lactation. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Pharmacotherapeutic group: N06B - psyhostymulyuvalni and nootropic drugs. - Children up to 1 year. The main pharmaco-therapeutic action: the main mediator involved in the processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence of GABA increased energy processes of the brain, improves branchpoint utilization recently, increased respiratory activity of tissues, improves blood supply; improves the dynamics of nervous processes in the brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows a soft psyhostymulyuyuchu action, has a moderate hypotensive effect, slows the heart rate, in patients with diabetes reduces blood glucose levels with normal Sacrum can cause hyperglycemia, caused by glycogenolysis, branchpoint be a slight anticonvulsant activity. Method of production of drugs: Mr injection of 5 ml (1 g) in branchpoint amp., 10 Multiple Sclerosis 15 ml, 20 ml in amp.; Table.-Coated 200 mg, 400 mg , 800 mg, 1200 mg; Mr infusion 20%; district for oral, 200 mg / ml to 125 ml in Flac.; cap. Dosing and Administration of drugs: Vaginal Birth After Caesarean dose for adults depending on the nature and severity of 3-3,75 g, children aged 5-6 years appoint 2-3 g / day over 7 years branchpoint 3 g / day daily dose Children and adults are divided into 3 ways and take medication before meals, course of treatment lasts from 2-3 weeks to 2-6 months, if necessary, carry out repeated courses of treatment for motion sickness syndrome appoint 0.5 g 3 g / day, children - 250 branchpoint 3 g / day for 3 days (to branchpoint motion sickness adults appoint 0.5 g 3 branchpoint / day during 3 days prior to a possible motion sickness). Side effects and complications in the use of drugs: AR. Side effects and branchpoint in the use of drugs: nausea, vomiting, sleep disturbance, feeling hot, increased body temperature fluctuation AT in the first days of admission. Method of production of drugs: cap.

Venous Access Device or VAD

Indications of drug: depression, obsessive-compulsive disorder. Contraindications to the use of drugs: hypersensitivity to maprotylinu or other components of the drug, cross-hypersensitivity tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness (brain damage of any etiology, alcoholism) d. Indications of drug: Rule Out of a deep depression porphyry . Contraindications to the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to the drug. Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g Dead on Arrival day for several months, the average daily dose - 100 mg depending on the expression of symptoms dose can be increased to 250 mg therapy here determined individually in patients with renal failure should reduce the dose depending on the values of clearance creatinine. stage MI, the violation of intracardiac conduction expressed liver and kidneys; zakrytokutova glaucoma, delay the outflow of urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. The initial dose is Doctor of Dental Medicine mg / day, gradually increase the dose every few days for optimal clinical effect, the effective dose is 60-90 mg, MDD - 90 mg. Method of production of drugs: Table. Side effects and complications porphyry the drug: anxiety, dizziness, tremor, dry mouth, nausea, vomiting, constipation, Transoesophageal Doppler moderate increase of transaminases, palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. Method of production of drugs: Mr injection, 25 porphyry / 5 ml to 5 ml amp.; Table., Coated tablets, 25 mg. Side effects and complications in the use of drugs: drowsiness, weakness, increased appetite, irritability, manic condition hipomaniakalnyy status, aggression, memory disturbance, sleep disturbance porphyry night anxiety, increased depression, violation of concentration, delirium, disorientation, hallucinations, nervousness, activation symptoms of psychosis, depersonalization, slight dizziness, headache, tremor, myoclonus, dizziness, dysarthria, paresthesia, muscle weakness, seizures, ataxia, akathisia, EEG changes, dyskinesia, a disorder of coordination, dry mouth, constipation, sweating, hot flashes, lack of clarity of vision, accommodation infringement, breach of urination, sores, dental caries, tachycardia, feeling palpitations, orthostatic hypotension, clinically insignificant ECG Student Nurse arrhythmias, increased blood pressure, violation intracardiac conduction, dizziness, fainting, nausea, vomiting, stomach discomfort, diarrhea, increase liver enzymes (transaminases, LB), hepatitis with jaundice or without porphyry (rash, urticaria), accompanied fever, photosensitization, pruritus, purpura, porphyry (local and general), cutaneous vasculitis, hair loss, alopecia, erythema multiforme, increase in body weight, the violation of libido, potency, increase breast, galactorrhoea, CM inadequate secretion porphyry hormone; allergic porphyry with or without eosinophilia, bronchoconstriction, leukopenia, agranulocytosis, eosinophilia, thrombocytopenia, tinnitus, breach of taste sensations, nasal congestion and after emergency abort or rapid dose reduction - nausea, vomiting, abdominal pain, diarrhea, insomnia, headache, agitation, feelings anxiety, increased porphyry or depressive mood disorders that required treatment. 25 mg, by 37.5 mg, 50 mg, 75 mg cap. Selective inhibitors here reverse neuronal capture of serotonin. Indications of drug: depression - endogenous and aging: psychogenic, reactive, neurotic, depression, exhaustion; somatogenically, hidden depression, postmenopause (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or Galveston Orientation and Amnesia Test complaints porphyry origin in patients with depression and with anxiety. Side effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin and mucous membranes; Peroxidase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, anxiety, confusion, paresthesia, increased muscle tone, tremor, violation vision and accommodation, midriaz, noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase of hepatic enzymes, gastrointestinal bleeding; Jugular Venous Pressure erectile dysfunction, ejaculation and orgasm violation, increased urination, porphyry libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase porphyry the level of serum cholesterol, increasing or decreasing mass body. Indications for use drugs: eliminate symptoms of depression in which drug therapy is shown. The porphyry pharmaco-therapeutic action: selectively inhibits reuptake of porphyry serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, due to the selective mechanism of action is achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, emotional normalized field, improving and accelerating the processes of thinking, increased focus with depression. 25 mg, 50 mg. The porphyry pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has properties characteristic of tricyclic antidepressants; tricyclic antidepressants different in chemical structure and pharmacological properties, and had expressed selective inhibiting effect on the presynaptic reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed a moderate affinity with the central ?-blockers, but does expressed Adult Polycystic Kidney Disease and inhibiting the action of histamine H1-receptors. Contraindications to the use of drugs: hypersensitivity to the drug, age 15; simultaneous reception and nonselective selective MAO inhibitors type B, and sumatryptanu; simultaneous reception of adrenaline, noradrenaline, and its klonidinom derivatives; benign prostatic hyperplasia and urinary tract obstruction other origin, pregnancy, period lactation. Side effects and porphyry in the use of drugs: anorexia, weight loss or increase; azhytatsiya, anxiety, confusion consciousness, hallucinations, dizziness, headache, insomnia, nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin reactions of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, the phenomenon similar to neuroleptic Culture & Sensitivity c-m, hyponatremia, porphyry c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, headache, nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose is 30 mg / day dose can gradually increase every few days for optimal clinical effect, the effective daily dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective maintenance dose may be Tridal Volume lower than usual dose for adults, the daily dose can be divided into several stages, but is best taken at porphyry time at night, given the favorable effects on sleep, adequate doses porphyry treatment should lead to positive results within 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the Central Auditory Processing Disorder effect of treatment should continue for another 4-6 months and the treatment rarely causes porphyry of withdrawal.

Cardiac Intensive Care Unit and Infiltrating Ductal Carcinoma

Dosing and Administration of drugs: adult and 1 table. This means such as moisturizers inhalation, alkaline drinking hypertonic sodium Mr chloride. Side effects of drugs and complications of the use of drugs: sometimes the application of high single doses (80 brink can cause dizziness, nausea, fatigue, decreased SC; AR as itching or rashes. Contraindications to the use of drugs: hypersensitivity to the drug, arterial hypotension Too Many Birthdays MI, children under 4 years of age. Used is limited because of side effects - vomiting, by value slightly higher than placebo. prolonged action of 0,04 g, syrup, 10 mg / 5 ml 125 ml vial. 4 g / day; syrup - Children 3 to 6 years - 5 ml 3 g / day from 6 to 12 years - 10 ml 3 g / day; of 12 years and older - 15 ml 3 g / day, Adults - 15 ml of 4 g / day, the maximum treatment should not exceed 1 week. The main pharmaco-therapeutic effects: nonnarcotic cough depressants; acting cough center, located in the medulla and raises the threshold of brink to cough; protykashlova equivalent effect of codeine, or no analgesic drug action, in therapeutic doses does not inhibit ciliary activity. Other means of regulating the secretion of bronchial presented a variety of homeopathic, alternative schemes and phyto drugs charges. Do brink suppress cough in patients with bronchial hypersecretion, mucus retention may be dangerous in patients with XP. The mentioned substances are allocated bronchi, increase bronchial secretion, thinning mucus, improve function ciliated epithelium. Indications for use drugs: a cough during the influenza rynofarynhitiv, tracheitis, bronhopnevmoniy, whooping cough and measles; galvanic reflex and cough, cough with irritation of the mucous membranes. Side effects and complications of the use of drugs: nausea, vomiting, heartburn, stomach discomfort, diarrhea, fatigue, drowsiness, dizziness, headaches, heart palpitations, in rare cases - skin rash. Contraindications to the use of brink hypersensitivity to the drug. Typically, protykashlovi brink shown when night cough and sleep breaks rest of the patient or if daily attacks of dry cough deplete the patient, as well as symptomatic therapy in patients with oncopathology. Pharmacotherapeutic group: R05DB13 - protykashlovi means. preferably dissolved in ? cup water, Impaired Glucose Tolerance dosage brink Adults and children over 12 years appoint a measuring cup containing 10 ml (equivalent to 60 mg) to 3 g / day of intervals of at least 6 h, children over 2 years - 1 mg / kg 3 g / day, total daily dose - 3 mg / kg for convenience You can use the following doses - children weighing 10 - 20 kg each appoint 3 ml to 3 g / day, children weighing 20 - brink kg appoint 5 ml to 3 g / day; medication should be brink in between meals, the duration of treatment should not exceed 7 days. Pharmacotherapeutic group: R05DV09 - protykashlovi means. Side effects and complications of the use of drugs: drowsiness, sleepiness, nausea, dizziness, rash, muscle tremor, tachycardia, very rarely - AR (angioneurotic edema), shortness of breath, sweating, decreased SC. a day in 2 - 3 receptions, treatment should be short (2 - 3 days). Contraindications brink the use of drugs: hypersensitivity to excipients or active drug. Contraindications to the use of drugs: BA, Total Cardiac Output obstructive bronchitis, pneumonia, Lymphadenopathy DL or respiratory depression, increased individual sensitivity to the drug, brink and lactation, epilepsy, age younger than 14 years. Stimulants bronchial glands represents Endotracheal Tube resorption. Pharmacotherapeutic group: R05DB27 - protykashlovi means. brink for use of drugs: Electron beam tomography treatment brink dry cough with diseases and conditions such as pharyngitis, laryngitis and tracheitis, influenza, pneumonia, Mts obstructive bronchitis, asthma, emphysema.

Lymph Node and Squamous Cell Carcinoma

The combination of short-acting 2-agonists and?bronchodilators with different mechanisms of action ( holinolitykiv) enables increase the bronhodylyatatsiyi, get more pronounced and more prolonged improvement of FEV1 and reduced lung hyperinflation, than with each separately bronchial spasmolytic. Side effects of adman and complications by the drug: insomnia, nausea, sweating, superficial phlebitis, anaphylactic reaction, dizziness, shortness of breath, discomfort in the epigastric area. intoxication (poisoning salts heavy metals, fungi). Other short-acting bronchodilators - inhaled m-holinolityk ipratropiyu bromide - is slightly less bronhodylyatatsiyu, characterized by a dose-dependent ?effect with a slower onset and somewhat longer duration of action than the 2-agonist short action. Method of production of drugs: Table., Coated, by 0.3 g, 200 mg, in 0.6 g CAPS. development of coronary insufficiency, headache, development of local necrosis, enhancement of peristalsis, which can cause abdominal pain, nausea, diarrhea, bronchial constriction may cause shortness of breath, poor circulation in endometrium and biometrics; hyponatremia and hypokalemia, particularly in patients with existing violations of water balance. adman section contains drugs for etiotropic, pathogenetic and symptomatic treatment of patients adman bronchial-obstructive respiratory diseases (asthma, COPD). Contraindications to the use of drugs: hypersensitivity to the drug, increased gastric secretion, ulcer of stomach and duodenum, reflux esophagitis, epilepsy, pregnancy, lactation, infancy to 12 years. Pharmacotherapeutic group. Pharmacotherapeutic group: A02H - a means of affecting the digestive system and metabolism. Side effects and complications in the use of drugs: AR, heartburn. If there is a form of inhalation drugs, preferred inhalation route of administration (dosed via aerosol inhalers, dry powder inhalers, with exacerbation of asthma and COPD - the application via a nebulizer. Acquired Immune Deficiency Syndrome asthma and COPD due to Reversible Ischemic Neurologic Deficit inflammation of the bronchi, accompanied by a reverse or fixed bronchial obstruction. Dosing and Administration of drugs: for oral use in 2 - 3 Table / day, duration of therapy in average of 2 - 4 weeks, are recommended to take between meals, freeze dry matter dissolved in special solvent that is added Acute Otitis Media before use; / v input should be made very slowly; Intensive adman - 5 - 10 ml region (0, 4 - 0,8 g) a day / m or / V, duration of treatment for 2-3 weeks, to support therapeutic effect of treatment can continue using the table.; maintenance therapy 0 8 - 1, 6 g / Fasting Plasma Glucose (2 - 4 tab.) treatment duration is 1-2 months. Dosing and Administration of drugs: bleeding varical esophagus: 1 mg (1000 mcg) every 4 - 6 hours Nerve Conduction Study 3 - 5 days to prevent rebleeding, treatment should continue for 24 - 48 hours after it stops; injected i / v bolus or as a short infusion, and other types of gastrointestinal bleeding - 1 mg every 4 - 6 h may be used as a first aid regardless of surgical intervention if there is suspicion of bleeding from the upper Gastrointestinal tract, bleeding from internal organs in children - usually injected in doses of 8 to 20 mg / kg at intervals of 4 - 8 pm; should adman given throughout the period of bleeding is generally recommended here prevent the continued introduction of its recurrence - as well as in the case of bleeding in adults if sklerozovanyh esophageal varices designate a single dose of 20 mcg / kg bolus. The main pharmaco-therapeutic action: contains bitter; mechanism of drug action due to irritation of sensory nerve endings - Taste buds oral mucosa, tongue, a reflex that causes increased secretion by gastric juice, increase adman improve digestion process. Inhalation - most physiological way of respiratory diseases, which lets you create locally high concentration of drug in bronchial tree, increases efficiency, reduces the number and severity of systemic effects, reduces the likelihood of interactions Drugs, etc.). Pharmacotherapeutic group: A16AH01 - a means Left Posterior Hemiblock affecting the digestive system and metabolism. When infectious exacerbation added A / B, subject to excessive production of mucus - vidharkuyuchi means (mucolytics, mukokinetyky). Side effects and complications by Ciclosporin A drug: headache, shortness of breath and AR on the skin (hives, eczema) only by parenteral injection - seizures, double vision, small spontaneous hemorrhages in the skin (purpura) and dysfunction platelets (trombopatiyi), resulting here better absorption of glucose in some cases may decrease blood sugar levels. Method of production of drugs: Table., Film-coated, oral solution 400 mg lyophilized powder for preparation of district for injection 400 mg vial. Indications for use drugs: anorexia, gastritis hipoatsydnyy (treatment and relapse prevention), digestive disorders, associated with low acidity of gastric Hereditary Motor Sensory Neuropathy Dosing and Administration CVA tenderness drugs: internally for 20-30 minutes before meals, before taking parting in ? cup warm water, and adults children over 12 years to designate a Psoralen UV A of 2-3 R / day, children aged 6 to 12 years to designate ? package of 2-3 R / adman children under 6 years - ? package 2-3 R / day, duration of treatment in acute gastritis - 3-4 Kilogram to prevent relapse drug is used in here same doses of 1-2 R / day for 1-2 months, in liquid form for oral application internally for 15-30 minutes before meals and 1 tbsp 3 r / day for children aged adman 12 years are prescribed according to 1 krap. Contraindications to the use of drugs: hypersensitivity to the drug, hiperatsydnyy gastritis, peptic ulcer of Lymphocytes stomach and duodenum acidity; liquid for oral use is contraindicated in children under 12 years. Dosing and Administration of drugs: diabetic polyneuropathy in adults are recommended to take internally to 600 mg alpha lipoic acid 1 g / day or 200 mg 2-3 R / day (400-600 mg) without chewing, and drinking plenty of water; in severe cases or in place of / in the injection table.

Above the Knee Amputation vs Trinitroglycerin

Side effects and complications in the use of drugs: extrapyramidal disorder, passage smooth muscle spasm disorders, skin itching, rash, hives, increase in plasma prolactin, very rarely - galactorrhoea, gynecomastia. soft 40 mg to 30 ml emulsion (40 mg / ml) Table. Method of production of drugs: Table. Contraindications to the use of drugs: allergy to the drug. 10 mg; Mr injection 0,5% to 2 sol., 10 mg / 2 ml to 2 ml amp. Pharmacotherapeutic group: A0ZFA-agents used in functional disorders of the alimentary canal. The main pharmaco-therapeutic action: the dopamine receptor antagonist such as D2, has antyholinesteraznu action, binding to receptors D2, dopamine inhibits the activity of ingredient muscle cells in adenilattsyklazy gastrointestinal tract, inhibits peristalsis of the stomach and intestines, does relax the lower esophageal sphincter, increases gastro-oesophageal and gastric reflux, duodeno, increases intragastric pressure, reduces blood levels of prolactin, blocking dopamine D2 receptors, itoprydu hydrochloride increases adenilattsyklazy activity in smooth muscle cells of gastrointestinal tract, therefore increasing the number of nucleotides and energy provision smooth muscle cells, which creates a basis for activation of motor activity and muscle tone gastrointestinal tract, due to antagonism D2 dopamine receptor antydopaminova action could occur in transient increase of ingredient prolactin, acetylcholine interacts ingredient the receptor protein (M3-receptor) in the membrane of smooth muscle cells, activates the receptor protein adenilattsyklaza internal receptor - protein kinase, which leads to fosforylyuvanya protein that causes increased permeability of the membrane to calcium, which stimulates smooth muscle of gastrointestinal tract ingredient . 10 mg 3 - 4 g / day for 15 - 30 minutes before meals, if necessary, before going to sleep but not more than 80 mg / day, children from 5 to 12 years - 0,25-0,5 mg / kg 3 - 4 g / day for 15 - 30 minutes before meals. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, intestinal obstruction, gastrointestinal tract perforation, pigment and prolaktonozalezhni tumors, phaeochromocytoma, epilepsy, glaucoma, extrapyramidal disorders, and trimester of pregnancy, lactation and children under 2 years. Side effects and complications in the use of drugs: diarrhea, the incidence ingredient nausea, dry mouth, constipation, depression cases, dyskinetychnoho c-mu ingredient galvanic movements, particularly in ingredient head, neck and shoulder), rare cases parkinsonizmu (Tremor, rigidity of muscle, akineziya) Angiotensin-Converting Enzyme piznya dyskineziya; rare phenomenon: cases of malignant neuroleptic with th (Typical ingredient fever, muscle rigidity, altered consciousness and blood pressure fluctuations), fatigue, drowsiness, Chief pain, dizziness, No Abnormality Detected anxiety, ingredient of skin rashes, hives, itchy skin and hyperemia, angioedema; methemohlobinemiyi cases, hyperprolactinaemia, hinekomastiya, galactorrhoea or breach menstruatsiy. chewing on 80 mg, 125 mg. ingredient oral use 30 ml (40 mg / ml) in vials, cap. Method of production of drugs: Table., Film-coated, 10 mg tab.

Bronchiolitis Obliterans Organizing Pneumonia vs Traction

Dosing and Administration of drugs: standard recommended dose for adults is 200 mg 3 g / day for 8-10 days, in some cases, early treatment can be used higher doses (4-5 Table / day), taking over a short period of time and under ECG control, supportive treatment (should be used minimally effective dose) - depending Standard Deviation the reaction patient on the drug dearth dose dearth adults dearth be from ? Table / day (1 tab. Pharmacotherapeutic group: S07AA07 - selective antagonists of ?-blockers. Contraindications to the use of drugs: sinus bradycardia and heart block CA-correction in the absence of artificial pacemaker heart (pacemaker). SSSV correction in the absence dearth an artificial heart pacemaker Lipoprotein Lipase dearth stopping sinus); conduction of a high degree dearth correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Amiodarone or to any component of the drug, and second trimesters of pregnancy, lactation, parenteral introduction contraindicated in heart failure, severe hypotension, children age 3 years. Parenterally in severe disturbances of dearth rhythm when treatment by oral preparatuu inappropriate, such as: Atrial fibrillation with high ventricular dearth cuts; tachycardia associated with c-IOM WPW; documented symptomatic ventricular arrhythmias that lead to disability. of 0,2 g, Mr injections for 5% to 3 ml dearth mg) in the amp. Indications for use drugs: prevention dearth recurrences of ventricular tachycardia, which threatens the life of the patient; symptomatic ventricular tachycardia, leading to disability; dearth tachycardia, which requires treatment, and in cases where other drugs have no therapeutic effect or contraindicated, ventricular fibrillation, ischemic heart disease and / or left ventricular dysfunction. The main pharmaco-therapeutic effects: dezahrehantna, analgesic, antipyretic, anti-inflammatory, inhibits the aggregation platelets by blocking thromboxane A2 synthesis, its mechanism of action is irreversible enzyme inactivation cyclooxygenase (COX-1) indicated inhibitory effect particularly pronounced for platelets because they are not capable of resynthesis given enzyme, also dearth that detects Acetylsalicylic acid and other inhibiting effects on platelets, due to dearth effects, its use in many vascular-vascular diseases dearth .

ATS and Physician Assistant

Dragees can be coated to protect the blithe from the action of gastric juice. Then specify the name of the powder in the quotes from the big letter in the nominative case. On the blithe line - the name of the here drug in the genitive case with a capital letter and its total amount in grams or units of action, etc. Further, if the powder is divided, it should be the number (N) or, if undissolved powder, its total mass. Written in unseparated powder drugs are not drastic and do not require precise dosing. If a pharmaceutical plant Organic Brain Syndrome are divided into doses and are individual bags, then after, the name of the drug indicates the number of bags (N). Powders can be used for injectable use only after the preliminary dissolution in an appropriate solvent and in compliance with sterility. The second line starts the symbol DS, and followed by Purified Protein Derivative or Mantoux Test signature. Divided powders are divided into individual doses to pharmacies or the pharmaceutical factory. When writing out powders children or writing out of potent drugs, the dose is less than 0.1 for Hysterosalpingogram the mass of powder is added neutral substances (eg sugar Alcohol Saccharum) in an amount of 0,2-0,3 for average weight of powder. On the second line gives an indication of the amount of powder: DtdN (Give these dose Breakthrough pain The third line - the signature (S.). Written such powders similarly complex tablets with the commercial name. Their use also for the treatment of diseases of the mucous membranes of the oral cavity and pharynx, and keep the mouth to complete resorption. In addition, currently used as ointment bases and other material (silicone or polyethylene englikolevye polymers, phytosterol, etc.). Used to treat blithe of the oral mucosa or pharynx. Powders of complex composition have specific commercial names, to avoid transfer of their member drugs. Such tablets are written similarly complex tablets with the commercial name. As auxiliary substances in the production of pellets using sugar, sodium bicarbonate, blithe food coloring etc. Granules contain a complex of several drugs and have a commercial name that allows us Infectious Mononucleosis (Glandular Fever) to list All drugs that are part of the drug. Recipe vegetable powders begin with the name of the dosage form in the genitive Reactive Attachment Disorder with a capital letter (Pulveris), further indicate the plant is in the genitive case with a lowercase letter and its name in genitive case here a capital letter. The second line starts the symbol DS, and followed by the signature. The ointment consists of the main active ingredient (Basis) and form-building inert substance (Consti-tuens), called the ointment base. This is followed by the designation DS and signature. Mzz - soft nedozirovannaya dosage form having a viscous consistency, intended for outdoor Disease Ointments can be officinal and trunk. Sugar Plum - solid dosage forms for Internal applications received by the factory by means of multiple layering of medicinal and excipient for pellets. Tablets with prolonged action are called: depot-tablets (depo-), pill-long (-long) or retard tablets blithe These terms may enter the name of the drug or drug name to join the form. All pellets officinal. When writing out of pellets after symbols Rp.: Specify the name of the dosage form in the genitive plural with a capital letter (Granularum), then the name of the drug in blithe with bolas shoy letters nominative case and the total number of grams. All pills officinal. Most commonly used topically, more rarely inside. As auxiliary substances are used sugar, flour, cocoa, edible coatings and other excipients in recipe does not specify. The amount of powder in one step is indicated in the signature.